LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 7.06 | 27.76 | 623 | 360 | 1.7306 | 1.3198 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 7.06 | 27.76 | 22 | 360 | 0.0611 | -0.0610 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 7.06 | 27.76 | 812 | 360 | 2.2556 | 1.4922 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 8.76 | 27.76 | 686 | 401 | 1.7101 | 1.2988 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 8.76 | 27.76 | 37 | 401 | 0.0922 | 0.0774 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 8.76 | 27.76 | 880 | 401 | 2.1937 | 1.4523 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 10.46 | 27.76 | 1 | 438 | 0.0023 | -0.5660 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 10.46 | 27.76 | 731 | 438 | 1.6665 | 1.2737 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 10.46 | 27.76 | 139 | 438 | 0.3169 | 0.4986 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 10.46 | 27.76 | 866 | 438 | 1.9743 | 1.3725 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 12.17 | 27.76 | 1 | 489 | 0.0020 | -0.5520 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 12.17 | 27.76 | 764 | 489 | 1.5621 | 1.2276 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 12.17 | 27.76 | 259 | 489 | 0.5296 | 0.7153 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 12.17 | 27.76 | 1011 | 489 | 2.0672 | 1.3836 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 13.87 | 27.76 | 1 | 604 | 0.0017 | -0.5265 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 13.87 | 27.76 | 815 | 604 | 1.3477 | 1.1389 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 13.87 | 27.76 | 776 | 604 | 1.2833 | 1.1154 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 13.87 | 27.76 | 1008 | 604 | 1.6669 | 1.2436 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 15.58 | 27.76 | 6 | 685 | 0.0088 | -0.2819 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 15.58 | 27.76 | 860 | 685 | 1.2544 | 1.1004 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 15.58 | 27.76 | 852 | 685 | 1.2428 | 1.0962 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 15.58 | 27.76 | 1015 | 685 | 1.4805 | 1.1770 | MN20160318_Q01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 17.28 | 27.76 | 180 | 838 | 0.2146 | 0.4626 | MN20160318_Q01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 17.28 | 27.76 | 909 | 838 | 1.0838 | 1.0330 | MN20160318_Q01 | D10 |